Insurance After 65

Sandra Kowalski is 66, a retired administrative director from Hartford, Connecticut, and she chose Medicare Advantage at 65 for the dental and vision coverage. The plan had a $0 premium. It covered two dental cleanings a year, a new pair of eyeglasses every two years, and a fitness reimbursement she used once. Her first year on the plan required no major medical services. She had a mammogram, an annual physical, and a flu shot. The plan worked exactly as advertised.

In her second year, Sandra was diagnosed with breast cancer. Her oncologist was out of network. Her preferred hospital, where her friend who was a breast cancer survivor had been treated, was out of network. Her specialist referrals required prior authorization. The first authorization request for a PET scan was denied. She appealed. The appeal took eleven days. The second authorization for a specific chemotherapy protocol was denied, approved on appeal, then denied again when the treatment plan changed after the second cycle. The dental coverage she chose the plan for provided a $1,200 maximum annual benefit. Her out-of-pocket medical costs in year two: $14,800.

Sandra made a reasonable choice at 65 with the information available to her. The information available to her was a 47-page Summary of Benefits document, a comparison tool on Medicare.gov she used for twenty minutes, and the advice of a friend who had been on the same plan for three years without needing it. Nobody told her what the plan would look like from the inside of a cancer diagnosis.

The Two Systems

#

Medicare offers two paths, and the choice between them is the most consequential healthcare decision most people make at 65. The paths look similar on paper. They function very differently when the person using them gets sick.

Original Medicare consists of Part A for hospital coverage and Part B for outpatient services. Most people add a Medigap supplemental policy to cover the copays and deductibles that Part A and Part B leave behind, and a Part D plan for prescription drug coverage. Under Original Medicare, the patient can see any physician and use any hospital that accepts Medicare, which is nearly all of them. There are no network restrictions. There are no prior authorization requirements for most services. There are no referral requirements to see a specialist. The cost is higher: a Medigap policy in most states runs $150 to $400 a month depending on the plan letter and the applicant’s age.

Medicare Advantage, also called Part C, is a private insurance plan that replaces Original Medicare. The plans are offered by companies like UnitedHealthcare, Humana, Aetna, and others, and they receive a fixed per-member payment from the federal government. Many have $0 premiums. Most include dental, vision, hearing, and fitness benefits that Original Medicare does not cover. The trade-off is network restrictions, prior authorization requirements, and annual out-of-pocket maximums that can reach $8,300 or higher for in-network services.

The $0 premium is the fact most people see first. The network restriction is the fact that matters when they are sick. Sandra saw the dental coverage and the $0 premium. She did not see the network that would exclude her oncologist or the prior authorization process that would delay her treatment by weeks during a cancer diagnosis.

The Network Adequacy Problem

#

Network adequacy means something different when you are healthy than when you are seriously ill. Sandra’s Medicare Advantage plan had an adequate network for routine care. Her primary care physician was in network. Her annual mammogram was in network. Her pharmacy was in network. For the first year, the network served her.

When she was diagnosed with breast cancer, the network’s adequacy changed. The oncologist her friend recommended, the one who had treated her friend’s similar diagnosis successfully, was not in the plan’s network. The cancer center where that oncologist practices, which is consistently ranked among the top breast cancer treatment programs in Connecticut, was not in the plan’s network. The plan had oncologists. It had cancer treatment facilities. They were not the ones Sandra wanted, and in cancer treatment, the physician and the facility matter in ways they do not for a flu shot.

The plan’s network was technically adequate by the regulatory standard. It had a minimum number of oncologists within a defined radius. The regulatory standard does not measure whether those oncologists specialize in the patient’s specific cancer type, whether they practice at a facility with the treatment protocols the patient’s case requires, or whether the patient has any basis for confidence in them. Regulatory adequacy and clinical adequacy are different measurements, and the gap between them is where Sandra lives.

Prior Authorization

#

Prior authorization is the process by which the insurance company reviews and approves a service before the patient receives it. For Original Medicare, prior authorization applies to a limited set of services. For Medicare Advantage, prior authorization applies to most specialist referrals, imaging procedures, surgical procedures, and many drug therapies.

For Sandra, prior authorization meant this: her oncologist ordered a PET scan to stage her cancer. The scan required prior authorization from her plan. The plan denied the request. Sandra’s oncologist appealed. The appeal took eleven days. During those eleven days, Sandra knew she had cancer and did not know how far it had spread. She could not begin treatment planning until the staging was complete. She could not complete the staging until the scan was approved. Eleven days is not administrative inconvenience when you have cancer. It is the time between knowing and acting, and every day of it felt like a week.

The second authorization denial, for a change in chemotherapy protocol after two cycles, was worse because it came after treatment had begun. Her oncologist adjusted the protocol based on how her cancer responded to the first two cycles. The adjustment required a different drug. The different drug required a new prior authorization. The authorization was denied, appealed, and eventually approved, but the gap between the denial and the approval added eight days to a treatment timeline that her oncologist had designed around specific intervals.

Studies from organizations including the American Medical Association have documented the extent of the prior authorization burden. Physicians report spending an average of nearly two business days per week on prior authorization activities. More than a third of physicians report that prior authorization has led to a serious adverse event for a patient in their practice. The system is designed to control costs by adding review steps before services are delivered. The cost it controls is the insurer’s. The cost it imposes is the patient’s time, anxiety, and in some cases, clinical outcome.

The Annual Reassessment

#

Every Medicare plan changes its formulary, premiums, network composition, and prior authorization requirements annually. The plan Sandra chose at 65 is not the same plan she has at 66, even though the name has not changed. Medications move on and off formularies. Physicians enter and leave networks. Prior authorization requirements expand or contract. The plan that was optimal for a healthy 65-year-old may not be optimal for a 66-year-old managing a cancer diagnosis.

Medicare’s Annual Enrollment Period runs from October 15 to December 7 every year. During this window, any Medicare beneficiary can switch plans. The problem is not access to the enrollment period. The problem is that most beneficiaries do not review their plan annually, and the review requires comparing their current health status, medication list, and provider relationships against the plan’s current terms, which have changed since last year in ways the plan does not prominently advertise.

A financial agent that runs the annual comparison automatically, using the patient’s current medication list and provider network, and flags when switching makes sense, closes a gap that costs many seniors hundreds to thousands of dollars per year. Sandra’s plan was not optimal for her medications in year two even before the cancer diagnosis. A Part D plan available during the previous enrollment period would have saved her $380 in annual copays. She never checked. Most people never check.

The SHIP Option

#

State Health Insurance Assistance Programs exist in every state and provide free, unbiased Medicare counseling from trained volunteers. SHIP counselors do not sell insurance. They are not compensated by any plan. They help Medicare beneficiaries understand their options, compare plans, and navigate enrollment decisions. The program is funded by the federal government through CMS and administered at the state level.

Most people eligible for SHIP counseling have never heard of it. The program is not widely advertised. The counselors are available by phone and in person, often at senior centers, libraries, and Area Agencies on Aging. The quality of counseling is generally high because the counselors are trained specifically on Medicare and have no financial incentive to recommend any particular plan.

An agent that locates the nearest SHIP counselor, explains what the program offers, and schedules an appointment is providing genuine value by connecting the user with a free public resource. For the person making the Medicare decision at 65, a SHIP consultation before enrollment is worth more than any comparison website, because the counselor can ask the questions the comparison tool cannot: what are your current medications, who are your current physicians, do you travel, do you have a chronic condition that may require specialist care you have not yet needed.

What No Tool Fully Addresses

#

Medicare plan comparison, whether done by an AI agent, a SHIP counselor, or the Medicare.gov Plan Finder, optimizes against known variables. It compares plans based on current medications, current providers, and current health status. What it cannot do is predict the health needs you do not yet have.

Sandra chose Medicare Advantage at 65 because she was healthy at 65. The plan was optimized for a healthy person. Cancer was not in her plan comparison because cancer was not in her life. No comparison tool would have told her at 65 that she would be diagnosed with breast cancer at 66, and no comparison tool can fully account for the possibility that any healthy person may become seriously ill in ways that change which plan is the right plan.

What a comparison tool can do is model scenarios. If you develop a condition that requires specialist care outside your current network, what does this plan cost? If you need a drug that is not on this formulary, what are your options? If prior authorization delays treatment by two weeks, how does that affect the clinical scenarios your physician is most concerned about? These are not comfortable questions. They are the questions that turn the insurance decision from a premium comparison into a healthcare decision, which is what it actually is.

Sandra’s Decision Two Years Later

#

Sandra wants to switch to Original Medicare with a Medigap supplement. In most states, Medigap policies are subject to medical underwriting after the initial open enrollment period around age 65. Sandra now has a cancer diagnosis on her medical record. Several Medigap insurers have declined to offer her a policy. One offered a policy at a rate 60% higher than the standard premium for her age.

The decision she made at 65, in good faith, with reasonable information, has compounded. The $0 premium saved her roughly $3,600 in the first two years. Her out-of-pocket costs in year two alone were $14,800. The oncologist she wanted was not available through her plan. The treatment delays from prior authorization added weeks to a timeline measured in weeks. And the path back to Original Medicare, where she would have had no network restrictions and no prior authorization delays, is now blocked or prohibitively expensive because of the medical underwriting rules in her state.

Sandra did not make the wrong choice. The decision architecture asked her to make an irreversible healthcare choice at a moment when she had the least relevant information, in a comparison framework that emphasizes premiums over the clinical dimensions that matter when the person gets sick. The agent that shows Sandra’s younger self the full picture, including the scenarios she hopes never happen, does not guarantee she makes a different choice. It guarantees she makes the choice knowing what she is choosing.